Background illustration for clinical trials search

Oncology Clinical Trials

Browse 8,977 oncology clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT05183048

Early_phase1, Recruiting

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer

for
Breast Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT04523857

Phase2, Recruiting

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Southfield MI
Sponsor: St. John Providence Health System

Sex: All

Age: 18+

Code: NCT00150657

Phase2, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Miami FL, Charleston SC,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

for
Primary Ciliary Dyskinesia
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 2 - 70+

Code: NCT05287022

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

SBRT With Atezo/Bev for HCC

for
Hepatocellular Carcinoma
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18 - 70+

Code: NCT05488522

Phase1, Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

for
Muscle-Invasive Bladder Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06529822

Phase1, Recruiting

Asciminib Roll-over Study

for
Chronic Myelogenous Leukemia,
Location: New York NY, Montreal, Ann Arbor MI, Milwaukee WI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 7 - 70+

Code: NCT04877522

Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

for
Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma
Location: Chapel Hill NC, Nashville TN, Denver CO
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT06940739

Phase1, Phase2, Recruiting

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

for
Cancer Patients, Care Givers
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 40+

Code: NCT06305741

Recruiting

Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

for
Breast Cancer
Location: New York NY
Sponsor: New York Presbyterian Hospital

Sex: Female

Age: 30 - 70+

Code: NCT00808522

Phase3, Recruiting

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial

for
Lung Carcinoma, Esophageal Carcinoma
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT05775939

Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

for
Hepatocellular Carcinoma
Location: St Louis MO, Houston TX, Los Angeles CA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06795022

Phase1, Phase2, Recruiting

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04560322

Phase2, Recruiting

Natural History of Familial Carcinoid Tumor

for
Carcinoid
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70+

Code: NCT00646022

Recruiting

Study With [225Ac]Ac-FL-020 in mCRPC Participants

for
Metastatic Castration-resistant Prostate Cancer
Location: Charlottesville VA, Cleveland OH, Duarte CA, Irvine CA,
Sponsor: Full-Life Technologies GmbH

Sex: Male

Age: 18+

Code: NCT06492122

Phase1, Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

for
Lymphoma, Chemotherapeutic Toxicity
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 60+

Code: NCT04053439

Recruiting

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

for
Papillomavirus Vaccines
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 8 - 70+

Code: NCT06535139

Recruiting

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05192122

Phase1, Recruiting

Hypofractionated WPPT With HDR Boost

for
Prostate Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06591819

Phase2, Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer